The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study

NCT03903588 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2020-10-22

No results posted yet for this study

Summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess two grids.

Conditions

  • Retinal Layer Separation

Interventions

DEVICE

Optical Coherence Tomography

Imaging of the Retina

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-22
Primary Completion
2019-09-12
Completion
2019-09-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903588 on ClinicalTrials.gov